Desogestrel PCD Pharma Franchise Company
Cafoli Lifecare offers Desogestrel as a tablet formulation, manufactured in WHO-GMP certified facilities. Distributors serving gynaecology and family-planning prescribers can secure district-wise monopoly franchise rights for this progestin-only oral contraceptive with full promotional support.
What is Desogestrel?
Desogestrel is a third-generation progestogen used as a progestin-only oral contraceptive (the mini-pill). It prevents pregnancy chiefly by inhibiting ovulation and thickening cervical mucus, and is suitable for women who cannot take oestrogen, including during breastfeeding. Reference: PubChem - Desogestrel.
Available Forms
The Cafoli Desogestrel portfolio is offered as oral Tablets in the standard 75 microgram progestin-only pill format. Contact us for current pack presentations and trade offers.
Therapeutic Applications
Desogestrel is used for oral contraception, particularly as an oestrogen-free option for breastfeeding mothers and women with contraindications to combined pills. Prescribers include gynaecologists, family-planning physicians and general practitioners.
Why Desogestrel is a High-Potential Molecule for Distributors
Progestin-only pills fill an important niche for oestrogen-free contraception, and demand is steady from postpartum and breastfeeding women who need a safe daily option. As a repeat-purchase, cycle-after-cycle product prescribed across gynae and family-planning practice, desogestrel offers distributors dependable recurring women-health volume.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.
References
- PubChem: Desogestrel
- MedlinePlus: Desogestrel oral contraceptive
- WHO Essential Medicines List - desogestrel
Our formulations of Desogestrel find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: